Related Experiment Videos
Response to the Comments on Rimassa et al.: "Systemic Treatment Options in Hepatocellular Carcinoma"
Lorenza Rimassa1, Tiziana Pressiani1, Philippe Merle2
1Medical Oncology and Hematology Unit, Humanitas Cancer Center, Humanitas Clinical and Research Center - IRCCS, Rozzano (Milan), Italy.
Liver Cancer
|May 14, 2020
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Longitudinal liquid biopsy and matched radiomic analysis indicated resistance mechanisms of patients with biliary tract cancer undergoing systemic treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Systemic treatment paradigms for unresectable and advanced hepatocellular carcinoma in Europe.
The Lancet regional health. Europe·2026
Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinoma.
JHEP reports : innovation in hepatology·2026
Comparative outcomes of advanced medical rescue therapies in steroid-refractory acute severe ulcerative colitis: a systematic review and network meta-analysis.
Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Early multimodal vasopressor strategy in septic shock: results of the TRICYCLE randomized controlled trial.
Critical care (London, England)·2026
Long-term outcomes of prophylactic cardioprotection in early-stage breast cancer patients on non-anthracycline anti-HER2 therapy.
Cardio-oncology (London, England)·2026
Continuous infusion of granulocyte colony-stimulating factor is associated with an advantage in neutrophil recovery in pediatric oncologic disorders.
Cancer chemotherapy and pharmacology·2026
Ciprofloxacin beyond antibacterial therapy: pharmacological mechanisms, anticancer activity, and translational limitations.
Naunyn-Schmiedeberg's archives of pharmacology·2026